RHY 1.22% 8.1¢ rhythm biosciences limited

Dear Supporter of OB,Thank you for your message. Just to...

  1. 706 Posts.
    lightbulb Created with Sketch. 638
    Dear Supporter of OB,Thank you for your message. Just to clarify, I am not Anthony or Adrian, and I am not one of the requisitioning shareholders. Your belief that OB's unpopularity is only amongst the requisitioning shareholder group appears objectively misguided (just look at the share price/demand v. supply and or this forum). Regarding the AFR article, let's avoid gaslighting. The article I linked to contains the relevant correction. While the correction addressed the percentage of shares sold and the buyer, it didn't alter the fundamental substance of the article did it? The key concern remains the timing of OB's share sale in relation to TGA request for information (undisclosed to the market at the time). The AFR correction seems to address only minor details, leaving the essential points intact. I'm open to correction if you can provide specific contrary details. If not, let's stay focused on the substantive issues rather than getting caught up in immaterial semantics. Speaking of which, another worth highlighting may be post the reported sale, OB likely has the least skin in the game, having probably recouped his initial capital with a healthy profit, in contrast to suggestions in the NOM that he holds the most. I welcome your thoughts on that also. Next, we can look at the failed commercialisation strategy and execution et. al.
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
(20min delay)
Last
8.1¢
Change
-0.001(1.22%)
Mkt cap ! $20.13M
Open High Low Value Volume
8.2¢ 8.2¢ 8.1¢ $12.04K 147.3K

Buyers (Bids)

No. Vol. Price($)
1 7321 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 13376 1
View Market Depth
Last trade - 11.53am 07/05/2024 (20 minute delay) ?
Last
8.1¢
  Change
-0.001 ( 2.41 %)
Open High Low Volume
8.2¢ 8.2¢ 8.1¢ 31384
Last updated 11.53am 07/05/2024 ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.